Article
Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.
Clinical and experimental rheumatology - 1 Jan 2000
Davis L A, Polk B, Mann A, Wolff R K, Kerr G S, Reimold A M, Cannon G W, Mikuls T R, Caplan L
Abstract excerpt
OBJECTIVES: Methotrexate (MTX) is the cornerstone medication in the treatment of rheumatoid arthritis (RA). We examined whether single nucleotide polymorphisms (SNPs) in enzymes of the folic acid pathway (folylpoly-gamma-glutamate synthetase [FPGS], gamma-glutamyl hydrolase [GGH], and methylenete...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
